Global Clinical Nutrition Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029
Clinical nutrition centers on the prevention, diagnosis, and management of nutritional changes in patients linked to chronic diseases and conditions primarily in health care. Clinical in this sense refers to the management of patients, including not only outpatients at clinics, but also (and mainly) inpatients in hospitals. It incorporates primarily the scientific fields of nutrition and dietetics. Furthermore, clinical nutrition aims to maintain a healthy energy balance, while also providing sufficient amounts of nutrients such as protein, vitamins, and minerals to patients.
Clinical nutrition is a kind of medicine product, which can keep patients' health by necessary nutrients such as protein, vitamins and minerals. These nutrients are helpful to improve metabolic function, release and body absorption.
Market Overview:The latest research study on the global Clinical Nutrition market finds that the global Clinical Nutrition market reached a value of USD 36483.0 million in 2022. It’s expected that the market will achieve USD 53678.0 million by 2028, exhibiting a CAGR of 6.65% during the forecast period.
India has the largest number of malnourished children in the world. Although the government is carrying out various programs focusing on maternal and infant nutrition, the recently released data of National Family Health Survey-5 (2019-2020) shows that compared with the previous survey, children's wasting has increased in Telangana, Kerala, Bihar and Assam. In addition, in a few States, such as Telangana, Kerala, Himachal Pradesh and Goa, the phenomenon of child stunting has increased. These trends were seen before the Covid-19 pandemic hit the country. Therefore, the impact of the pandemic will only aggravate the problem.
The COVID-19 pandemic is expected to have a significant impact on the Clinical Nutrition product market. Because the nutritional management needs, especially those of children and the elderly, continue to grow continuously. In the ongoing COVID-19 crisis, the demand for clinical nutrition products is rising. Because consumers are looking for a variety of immune-enhancing alternatives to prevent infection with novel coronavirus.
However, the pandemic brought mobile restrictions and factory shutdown, which brought huge economic losses to India. The problems of many low-and middle-income people and poor people are getting worse, and the loss of income will not use people's money to buy Clinical Nutrition products, but to ensure basic living. In addition, the movement restriction and supply chain interruption lead to difficulties in raw material transportation, large-scale factory shutdown, and the brand has to adjust its strategy.
But in the long run. The outbreak of COVID-19 has enhanced people's health awareness, and people are more inclined to eat healthily and enhance their immunity. Therefore, after the pandemic, the Clinical Nutrition market will flourish. In addition, due to the epidemic, the Clinical Nutrition market has been further developed in the field of e-commerce.
DriversClinical nutrition is to relieve symptoms, promote rehabilitation and improve the quality of life after recovery by using food characteristics and adjusting metabolism in pathological state. According to the principle of nutrition, it can enhance the clinical effect of other treatment measures and accelerate the recovery of patients by treating meals, treating or relieving diseases. Clinical nutrition plays an important role in the treatment of diseases. The nutritional status of patients directly affects the healing of wounds and the recovery of diseases. Good nutritional status can delay the occurrence and development of some diseases, and nutrition can also be used as a treatment for some diseases.
In a word, clinical nutrition product is a kind of medicine which helps to keep patients healthy. They help to restore the body's metabolic system, namely vitamins and minerals, through adequate supplements. The increase of lifestyle, chronic diseases and the increasing number of people who need malnutrition treatment are the key factors to promote the growth of clinical nutrition market.
India is the second most populous country in the world after China. Most of the population is middle class and poor, and only a few belong to rich class. The country's economic situation is relatively poor from the nutritional point of view.
Limitations
The poverty rate in India is still relatively high, and some forms of Clinical Nutrition may be very expensive. A poor patient may not be able to afford such expenses. The price factor and high poverty rate are the main reasons that affect the growth of Clinical Nutrition market in India.
Indian women are faced with a series of demographic nutrition problems. In rural areas, women are the last consumer of the household, and her nutritional intake is far below the recommended value-leading to severe malnutrition. This is also true in urban slums or low-income groups. Malnutrition, micronutrient deficiency and imbalance are also prominent among urban middle-income or high-income groups. There are many reasons, such as: busy lifestyle, women don't put health first. The solidification of ideas and women's neglect of healthy nutrition are not conducive to the development of clinical nutrition market.
In addition, although the ICDS program run by the Indian government is the largest nutritional supplement program in the world, its coverage, quality and delivery have long faced implementation challenges. At the same time, it intensified with the Covid-19 pandemic.
Making up for the need of safety and quality standards of nutrition therapy is becoming a restrictive factor in clinical nutrition market. The lack of strict guidelines and knowledge on nutritional supplements in emerging countries such as India is expected to slightly hinder the growth rate of the market.
Region Overview:In global comparison, a significant portion of the revenue was generated in North America (38.66% in 2022).
Company Overview:Abbott Nutrition is one of the major players operating in the Clinical Nutrition market, holding a share of 17.62% in 2023.
Abbott Nutrition
Abbott Nutrition has many brands to meet the nutritional needs of infants, children, adults and patients.
Nestle SA
Nestle SA (Nestle) is a nutrition, health and wellness company. Its product portfolio comprises baby foods, bottled water, cereals, chocolate and confectionery, coffee, culinary products, chilled and frozen foods, dairy products, drinks, nutritional products, and ice-cream. It offers these products under seven categories, including powdered and liquid beverages, water, milk products and ice cream, nutrition and health science, prepared dishes and cooking aids, confectionery and pet care.
Segmentation Overview:By type, Oral segment accounted for the largest share of market in 2022.
Key Companies in the global Clinical Nutrition market covered in Chapter 3:Groupe Danone
Fresenius Kabi
Mead Johnson Nutrition Company
Abbott Nutrition
Nestle SA
B Braun Melsungen AG
Baxter International
Ostuka Pharmaceutical India Pvt. Ltd.
In Chapter 4 and Chapter 14.2, on the basis of types, the Clinical Nutrition market from 2018 to 2029 is primarily split into:Oral
Enteral
Parenteral
In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Clinical Nutrition market from 2018 to 2029 covers:Pediatric
Adult
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)